Joe Thompson is responsible for the science that substantiates Imperial Brands’ next-generation products as potentially reduced harm relative to continued smoking and the stewardship of Imperial’s products. He leads a large multidisciplined team of 200 people and a laboratory network spread over several countries. He has 24 years of experience in the science of tobacco and nicotine, risk assessment, and regulatory affairs.
Thompson is also the president of CORESTA (Cooperation Centre for Scientific Research Relative to Tobacco), a global organization with over 170 company, institute, and laboratory members. CORESTA is an authoritative source of publicly available, credible science and best practices related to tobacco products.
Thompson is a fellow of the Royal Society of Medicine and a European Registered Toxicologist with degrees in toxicology and physiology.
